DK102857C - Process for the preparation of 3-keto-6-trifluoromethyl-Δ <4,6> -pregnadienes. - Google Patents
Process for the preparation of 3-keto-6-trifluoromethyl-Δ <4,6> -pregnadienes.Info
- Publication number
- DK102857C DK102857C DK232161A DK232161A DK102857C DK 102857 C DK102857 C DK 102857C DK 232161 A DK232161 A DK 232161A DK 232161 A DK232161 A DK 232161A DK 102857 C DK102857 C DK 102857C
- Authority
- DK
- Denmark
- Prior art keywords
- pregnadienes
- keto
- trifluoromethyl
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2019060 | 1960-06-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK102857C true DK102857C (en) | 1965-10-18 |
Family
ID=10141901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK232161A DK102857C (en) | 1960-06-08 | 1961-06-08 | Process for the preparation of 3-keto-6-trifluoromethyl-Δ <4,6> -pregnadienes. |
Country Status (3)
Country | Link |
---|---|
CH (1) | CH401960A (en) |
DK (1) | DK102857C (en) |
ES (1) | ES268064A1 (en) |
-
1961
- 1961-06-08 DK DK232161A patent/DK102857C/en active
- 1961-06-08 ES ES0268064A patent/ES268064A1/en not_active Expired
- 1961-06-08 CH CH668161A patent/CH401960A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CH401960A (en) | 1965-11-15 |
ES268064A1 (en) | 1961-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK113988B (en) | Process for the preparation of 1,6-dibromo-1,6-dideoxy-D-mannitol. | |
DK112306B (en) | Process for the preparation of 2,6-dichloro-toluene derivatives. | |
DK104302C (en) | Process for the preparation of 4-fluoro-3,20-diketo-Δ <4> -21-bromopregnants. | |
DK101297C (en) | Process for the preparation of 3-keto-6α-trifluoromethyl-Δ <1,4> -pregnadienes. | |
DK102857C (en) | Process for the preparation of 3-keto-6-trifluoromethyl-Δ <4,6> -pregnadienes. | |
DK97513C (en) | Process for the preparation of the 3,11-dioxo-17α-hydroxy-20β, 21-dinitrato-Δ <4> -pregne. | |
DK98239C (en) | Process for the preparation of 2-alkoxy-3,17-diketo-11β-hydroxy-Δ <1,4> -androstadienes. | |
DK101056C (en) | Process for the preparation of 3-keto-6-trifluoromethyl-Δ <1,4,6> -pregnatrienes. | |
DK100166C (en) | Process for the preparation of 3,20-diketo-17α-hydroxy-21-acetoxy-16α-methyl-Δ <4.9 (11)> - pregnadiene. | |
DK100230C (en) | Process for the preparation of 3-amino-17β-acyloxy-Δ <1,3,5 (10), 9 (11)> estratetraenes. | |
DK100614C (en) | Process for the preparation of 3-amino-17β-acyloxy-Δ <1,3,5 (10) 9 (11)> estratetraenes. | |
DK96739C (en) | Process for the preparation of 3-keto-17β-hydroxy-17α-ethynyl-Δ <5 (10), 9 (11)> -estradiene. | |
DK96053C (en) | Process for the preparation of Δ <1,4> -3-ketosteroids. | |
DK97823C (en) | Process for the preparation of 3-alkoxy-Δ <3,5> -pregnadiene compounds. | |
DK99567C (en) | Process for the preparation of 4-oxa-tetracyclo- (6: 2: 1: 0 <2.7>: 0 <3.5>) - hendecane derivatives. | |
DK98001C (en) | Process for the preparation of 3-oxo-14-hydroxy-11α, 19-diacetoxy- (1,4) -cardadienolide. | |
DK94561C (en) | Process for the preparation of 3-acyloxy-2,4,6-pregnatrienes. | |
DK97819C (en) | Process for the preparation of 1-methyl-17α-alkyl- or 17α-vinyl-Δ <1> -androsten-17β-ol-3-ones. | |
DK98177C (en) | Process for the preparation of the 11β, 18-oxido-methyl-3,20-diketo-δ <4> -pregne. | |
DK104404C (en) | Process for the preparation of 10-alkenyl-δ <1,4> -3-keto-steroids. | |
DK108858C (en) | Process for the preparation of 19-hydroxy- or 19-acyloxy-Δ <4,6> -3-oxo-steroids. | |
DK97939C (en) | Process for the preparation of the 3,11,20-trioxo-18-nor-Δ <4> -pregne. | |
DK98496C (en) | Process for the preparation of 6-halo-1,2α-methylene-Δ <6> -17α-acyloxyprogesterones. | |
DK112870B (en) | Process for the preparation of 17α-methyl-Δ <1,4> -androstadien-17β-ol-3-one. | |
DK103076C (en) | Process for the preparation of derivatives of 5,6-dihydropyridones. |